A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
We tested the hypothesis that the apoptosis of inner retina neurons and increased expression of glial fibrillary acidic protein (GFAP) observed in the rat after a short duration of diabetes are mediated by polyol pathway activity. Rats with 10 weeks of streptozotocin-induced diabetes and GHb levels of 16 ± 2% (mean ± SD) showed increased retinal levels of sorbitol and fructose, attenuation of GFAP immunostaining in astrocytes, appearance of prominent GFAP expression in Müller glial cells, and a fourfold increase in the number of apoptotic neurons when compared with nondiabetic rats. The cells undergoing apoptosis were immunoreactive for aldose reductase. Sorbinil, an inhibitor of aldose reductase, prevented all abnormalities. Intensive insulin treatment also prevented most abnormalities, despite reducing GHb only to 12 ± 1%. Diabetic mice, known to have much lower aldose reductase activity in other tissues when compared with rats, did not accumulate sorbitol and fructose in the retina and were protected from neuronal apoptosis and GFAP changes in the presence of GHb levels of 14 ± 2%. This work documents discrete cellular consequences of polyol pathway activity in the retina, and it suggests that activation of the pathway and “retinal neuropathy” require severe hyperglycemia and/or high activity of aldose reductase. These findings have implications for how to evaluate the role of the polyol pathway in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Glial reactivity, an early feature of diabetic retinopathy.
Rungger‐Brändle, E., Dosso, A., & Leuenberger, P. (2000) · PubMed · Cited by 581
Müller cell changes in human diabetic retinopathy.
Mizutani, M., Gerhardinger, C., & Lorenzi, M. (1998) · Diabetes · doi:10.2337/diabetes.47.3.445 · Cited by 481
Self-citationLieth, E., Barber, A. J., Xu, B., Dice, C., Ratz, M. J., Tanase, D., & Strother, J. M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.815 · Cited by 467
Barber, A. J., Antonetti, D. A., & Gardner, T. W. (2000) · PubMed · Cited by 353
Arthur, F. E., Shivers, R. R., & Bowman, P. D. (1987) · Developmental Brain Research · doi:10.1016/0165-3806(87)90075-7 · Cited by 345
Polyol pathway and diabetic peripheral neuropathy
Oates, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50082-9 · Cited by 322
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
The role of müller cells in the formation of the blood-retinal barrier
Tout, S., Chan-Ling, T., Holländer, H., & Stone, J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90473-s · Cited by 268
Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies
Carelli, V (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00129-2 · Cited by 264
A Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110050024 · Cited by 228
Hammes, H. P., Lin, J., Bretzel, R. G., Brownlee, M., & Breier, G. (1998) · Diabetes · doi:10.2337/diabetes.47.3.401 · Cited by 222
Early cellular and molecular changes induced by diabetes in the retina
Lorenzi, M., & Gerhardinger, C. (2001) · Diabetologia · doi:10.1007/s001250100544 · Cited by 205
Self-citationAldose reductase inhibitors: therapeutic implications for diabetic complications
Oates, P. J., & Mylari, B. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2095 · Cited by 197
Chung, H. S., Harris, A., Ciulla, T. A., & Kagemann, L. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00037-8 · Cited by 172
Red Cell Sorbitol: An Indicator of Diabetic Control
Malone, J. I., Knox, G., Benford, S., & Tedesco, T. A. (1980) · Diabetes · doi:10.2337/diab.29.11.861 · Cited by 161
Immunohistochemical Localization of Aldose Reductase: II. Rat Eye and Kidney
Ludvigson, M. A., & Sorenson, R. L. (1980) · Diabetes · doi:10.2337/diab.29.6.450 · Cited by 146
Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives
van Dam, P. S. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.287 · Cited by 143
Localization of Aldose Reductase in the Human Eye
Akagi, Y., Yajima, Y., Kador, P. F., Kuwabara, T., & Kinoshita, J. H. (1984) · Diabetes · doi:10.2337/diab.33.6.562 · Cited by 117
A murine model of accelerated periodontal disease in diabetes
Lalla, E., Lamster, I. B., Feit, M., Huang, L., & Schmidt, A. M. (1998) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1998.tb02335.x · Cited by 95
M�ller cells in detached human retina express glial fibrillary acidic protein and vimentin
Okada, M., Matsumura, M., Ogino, N., & Honda, Y. (1990) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00927264 · Cited by 92
Aldose reductase and polyol in cultured pericytes of human retinal capillaries
Hohman, T. C., Nishimura, C., & Robison, W. G. (1989) · Experimental Eye Research · doi:10.1016/0014-4835(89)90018-3 · Cited by 75
Long-term effects of light damage on the retina of albino and pigmented rats.
Wasowicz, M. Y., Morice, C., Ferrari, P., Callebert, J., & Versaux‐Botteri, C. (2002) · PubMed · Cited by 70
IGF-I mRNA and Signaling in the Diabetic Retina
Gerhardinger, C., McClure, K. D., Romeo, G. R., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.1.175 · Cited by 62
Self-citationBek, T. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00395.x · Cited by 46
Glial cell involvement in vascular occlusion of diabetic retinopathy
Bek, T. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00764.x · Cited by 43
Verderber, L. C., Johnson, W., Mucke, L., & Sarthy, V. P. (1995) · PubMed · Cited by 39
Residues affecting the catalysis and inhibition of rat lens aldose reductase
Carper, D. A., Hohman, T. C., & Old, S. E. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00182-g · Cited by 27
The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience
Tout, S., Ling, T. C., Holländer, H., & Stone, J. (1993) · Cited by 25
Cited by
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Srivastava, S. K., Ramana, K. V., & Bhatnagar, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0028 · Cited by 527
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
Simó, R., & Hernández, C. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.005 · Cited by 490
Metadata
- Authors
- Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., & Lorenzi, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-02-01
- Volume
- 52
- Issue
- 2
- Pages
- 506-511
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2130816682
- Cited by
- 279
- References
- 31
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.